help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on June 18, 2009
Molecular Endocrinology, doi:10.1210/me.2009-0032
This Article
Right arrow Author Manuscript (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
23/9/1360    most recent
Author Manuscript (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow NURSA Molecule Pages Link
Right arrow Request Copyright Permission
Google Scholar
Right arrow Articles by Pippal, J. B.
Right arrow Articles by Fuller, P. J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pippal, J. B.
Right arrow Articles by Fuller, P. J.

Submitted on January 21, 2009
Accepted on June 11, 2009

Structural and functional characterisation of the interdomain interaction in the mineralocorticoid receptor

Jyotsna B. Pippal, Yizhou Yao, Fraser M. Rogerson, and Peter J. Fuller*

Prince Henry's Institute of Medical Research, P.O Box 5152, Clayton, VIC, 3168, Australia

* To whom correspondence should be addressed. E-mail: peter.fuller{at}princehenrys.org.

The mineralocorticoid receptor (MR) plays a central role in electrolyte homeostasis and in cardiovascular disease. We have previously reported a ligand-dependent N/C-interaction in the MR. In the present study we sought to fully characterise the MR N/C-interaction. By utilising a range of natural and synthetic MR ligands in a mammalian two-hybrid assay (M-2-H) we demonstrate that in contrast to aldosterone, which strongly induces the interaction, the physiological ligands deoxycorticosterone (DOC) and cortisol weakly promote the interaction but predominantly inhibit the aldosterone mediated N/C-interaction. Similarly, progesterone and dexamethasone antagonise the interaction. In contrast, the synthetic agonist 9{alpha}-fludrocortisol robustly induces the interaction. The ability of the N/C-interaction to discriminate between MR agonists suggests a subtle conformational difference in the ligand-binding domain induced by these agonists. We also demonstrate that the N/C-interaction is not cell-specific, consistent with the evidence from a GST pull-down assay, of a direct protein-protein interaction between the N- and C-terminal domains of the MR. Examination of a panel of deletions in the N-terminus suggests that several regions may be critical to the N/C-interaction. These studies have identified functional differences between physiological MR ligands which suggest that the ligand-specific dependence of the N/C-interaction may contribute to the differential activation of the MR which has been reported in vivo.


Key words: glucocorticoid • dexamethasone • ligand-binding • aldosterone

NURSA Molecule Pages Link:

Nuclear Receptors:   MR
Coregulators:   PIAS1
Ligands:   Deoxycorticosterone  |  Dexamethasone  |  Aldosterone  |  Progesterone






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2009 by The Endocrine Society